Combined Effects of Active Cycle Breathing Technique and Buteyko Technique in Post Sternotomy Patients
1 other identifier
interventional
32
1 country
1
Brief Summary
This randomized clinical trial seeks to compare the efficacy of the Active Cycle of Breathing Technique (ACBT) and Buteyko breathing techniques in sternotomy patients undergoing coronary artery bypass graft (CABG) surgery, aged 30 to 60. Data will be collected from Surgical Intensive Care Unit (ICU) in selected hospitals. Participants will be assigned to intervention to receiving ACBT and Buteyko breathing techniques standard protocol including chest percussion , tissue blowing exercises, incentive spirometer , cough technique, breathing control, deep breathing, and deep breathing techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2024
CompletedFirst Submitted
Initial submission to the registry
June 12, 2024
CompletedFirst Posted
Study publicly available on registry
June 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2024
CompletedJune 26, 2024
June 1, 2024
4 months
June 12, 2024
June 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Borg dyspnea scale
The Borg RPE scale rates exertion from a scale of 6 (no exertion) to 20 (maximum effort). A rating between 12 to 14 typically reflects a moderate or somewhat hard level of intensity.
base line and 4 week
BREATHLESSNESS, COUGH AND SPUTUM SCALE (BCSS)
The BCSS is a three-item patient-reported questionnaire that rates sputum, cough, and dyspnea . This instrument can identify a disease aggravation with sensitivity and specificity.
4 weeks
Study Arms (2)
ACTIVE CYCLE OF BREATHING TECHNIQUE
EXPERIMENTALGroup A: combine effects of ACBT and Buteyko techniques will be performed first 3days of cardiac rehab phase 1.
Buteyko techniques
EXPERIMENTALGroup B: effect of buteyko techniques will be performed first three days of cardiac rehab phase 1.
Interventions
Group A: combine effects of ACBT and Buteyko techniques will be performed first 3days of cardiac rehab phase 1.
Group B: effect of buteyko techniques will be performed first three days of cardiac rehab phase 1.
Eligibility Criteria
You may qualify if:
- Age 40-60 years
- Patient underwent cardiac surgery for first time
- Having speaking, hearing, cognitive ability
- Both genders ( Male and female)
- On mechanical ventilation for less than 24h after surgery
You may not qualify if:
- Hemodynamic ally unstable patients
- Patients with reopening of sternum
- Infection patients
- Renal failure
- Arrhythmia
- Patient on mechanical ventilator
- Cancer
- Tuberculosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulab Devi teaching hospital
Lahore, Punjab Province, 54000, Pakistan
Related Publications (3)
Cappello IA, Candelari M, Pannone L, Monaco C, Bori E, Talevi G, Ramak R, La Meir M, Gharaviri A, Chierchia GB, Innocenti B, de Asmundis C. 3D Printed Surgical Guide for Coronary Artery Bypass Graft: Workflow from Computed Tomography to Prototype. Bioengineering (Basel). 2022 Apr 19;9(5):179. doi: 10.3390/bioengineering9050179.
PMID: 35621457BACKGROUNDFrak W, Wojtasinska A, Lisinska W, Mlynarska E, Franczyk B, Rysz J. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. Biomedicines. 2022 Aug 10;10(8):1938. doi: 10.3390/biomedicines10081938.
PMID: 36009488BACKGROUNDKamiya K, Takei M, Nagai T, Miyoshi T, Ito H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, Daida H, Iimuro S, Shimokawa H, Kimura T, Nagai R, Anzai T. Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study. J Atheroscler Thromb. 2024 Jan 1;31(1):61-80. doi: 10.5551/jat.64304. Epub 2023 Aug 11.
PMID: 37574272BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Sidra Faisal, PP-DPT
Riphah International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2024
First Posted
June 26, 2024
Study Start
March 10, 2024
Primary Completion
July 15, 2024
Study Completion
August 20, 2024
Last Updated
June 26, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share